Live attenuated AIDS viruses as vaccines: promise or peril?
- PMID: 10566148
- DOI: 10.1111/j.1600-065x.1999.tb01335.x
Live attenuated AIDS viruses as vaccines: promise or peril?
Abstract
Live attenuated viruses can provide vaccine protection against various viral illnesses. A number of live attenuated strains of the simian immunodeficiency virus (SIV) or related lentiviruses have been evaluated in primate models as vaccine candidates against AIDS. Impressive efficacy was observed for some viruses, most notably SIV strains with deletions in the nef-gene. Sterilizing immunity was seen against homologous and heterologous virus challenge, against cell-free and cell-associated challenge, against intravenous and mucosal challenge, and against challenge as early as 3 weeks and as late as 2.25 years after just one immunization. However, these promising efficacy results are overshadowed by safety problems, such as reversion of the vaccine strain to a pathogenic virus encoding full-length nef or residual virulence of multiply deleted vaccine strains. Strategies aimed at decreasing the replicative capacity of nef-deleted vaccine strains to increase the safety profile have significantly curtailed vaccine efficacy. Nevertheless, studies of live attenuated vaccine strains should proceed and should focus on determining the correlates of vaccine protection and the molecular determinants for virulence and attenuation.
Similar articles
-
Live attenuated HIV vaccines: pitfalls and prospects.Curr Opin Infect Dis. 2004 Feb;17(1):17-26. doi: 10.1097/00001432-200402000-00004. Curr Opin Infect Dis. 2004. PMID: 15090885 Review.
-
Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.Vaccine. 2001 Dec 12;20(5-6):813-25. doi: 10.1016/s0264-410x(01)00408-x. Vaccine. 2001. PMID: 11738745
-
SIV vaccine for AIDS.Science. 1998 Jan 2;279(5347):14-5. doi: 10.1126/science.279.5347.10i. Science. 1998. PMID: 9441400 No abstract available.
-
Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.Arch Virol. 2004 Sep;149(9):1705-20. doi: 10.1007/s00705-004-0333-8. Arch Virol. 2004. PMID: 15593414
-
Mechanisms of protection against simian immunodeficiency virus infection.Vaccine. 2002 May 6;20(15):1985-7. doi: 10.1016/s0264-410x(02)00083-x. Vaccine. 2002. PMID: 11983259 Review.
Cited by
-
Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.J Virol. 2012 Sep;86(17):9188-200. doi: 10.1128/JVI.00532-12. Epub 2012 Jun 13. J Virol. 2012. PMID: 22696662 Free PMC article.
-
Delivery strategies for novel vaccine formulations.World J Virol. 2012 Feb 12;1(1):4-10. doi: 10.5501/wjv.v1.i1.4. World J Virol. 2012. PMID: 24175206 Free PMC article.
-
CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virus.J Virol. 2005 Oct;79(19):12264-72. doi: 10.1128/JVI.79.19.12264-12272.2005. J Virol. 2005. PMID: 16160152 Free PMC article.
-
Even attenuated bovine leukemia virus proviruses can be pathogenic in sheep.J Virol. 2007 Sep;81(18):10195-200. doi: 10.1128/JVI.01058-07. Epub 2007 Jul 11. J Virol. 2007. PMID: 17626096 Free PMC article.
-
DNA vaccines: ready for prime time?Nat Rev Genet. 2008 Oct;9(10):776-88. doi: 10.1038/nrg2432. Nat Rev Genet. 2008. PMID: 18781156 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
